HomeCompareAMIVF vs KMB

AMIVF vs KMB: Dividend Comparison 2026

AMIVF yields 8.97% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AMIVF wins by $255.15M in total portfolio value
10 years
AMIVF
AMIVF
● Live price
8.97%
Share price
$8.31
Annual div
$0.75
5Y div CAGR
69.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$255.20M
Annual income
$229,349,691.60
Full AMIVF calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — AMIVF vs KMB

📍 AMIVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAMIVFKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AMIVF + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AMIVF pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMIVF
Annual income on $10K today (after 15% tax)
$762.48/yr
After 10yr DRIP, annual income (after tax)
$194,947,237.86/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, AMIVF beats the other by $194,942,798.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMIVF + KMB for your $10,000?

AMIVF: 50%KMB: 50%
100% KMB50/50100% AMIVF
Portfolio after 10yr
$127.62M
Annual income
$114,677,456.97/yr
Blended yield
89.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

AMIVF
No analyst data
Altman Z
2.1
Piotroski
8/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMIVF buys
0
KMB buys
0
No recent congressional trades found for AMIVF or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAMIVFKMB
Forward yield8.97%5.25%
Annual dividend / share$0.75$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR69.4%17%
Portfolio after 10y$255.20M$45.9K
Annual income after 10y$229,349,691.60$5,222.34
Total dividends collected$253.18M$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: AMIVF vs KMB ($10,000, DRIP)

YearAMIVF PortfolioAMIVF Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$12,220$1,519.59$11,314$614.45+$906.00AMIVF
2$16,015$2,939.76$12,867$760.19+$3.1KAMIVF
3$23,235$6,099.64$14,713$945.27+$8.5KAMIVF
4$38,873$14,010.84$16,924$1,181.90+$21.9KAMIVF
5$78,704$37,109.80$19,596$1,486.64+$59.1KAMIVF
6$203,164$118,950.99$22,850$1,882.16+$180.3KAMIVF
7$703,512$486,126.81$26,849$2,399.80+$676.7KAMIVF
8$3,417,802$2,665,044.03$31,812$3,083.36+$3.39MAMIVF
9$24,154,947$20,497,898.70$38,033$3,994.72+$24.12MAMIVF
10$255,195,485$229,349,691.60$45,918$5,222.34+$255.15MAMIVF

AMIVF vs KMB: Complete Analysis 2026

AMIVFStock

Atrium Mortgage Investment Corporation, a non-bank lender, provides financing solutions to the real estate communities in Ontario, Alberta, and British Columbia. It offers various types of mortgage loans for residential, multi-residential, and commercial real properties, which includes first and second mortgages; infill construction and financing; land and land assembly financing for stacked and traditional townhomes, single detached homes, and low-rise and midrise condominiums; and bridge and term financing. The company was incorporated in 2001 and is headquartered in Toronto, Canada.

Full AMIVF Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this AMIVF vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMIVF vs SCHDAMIVF vs JEPIAMIVF vs OAMIVF vs KOAMIVF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.